[1] |
WANG Zifei, DING Yahui, LI Yan, LUAN Xin, TANG Min.
Application of 3D bioprinting in cancer research and tissue engineering
[J]. China Oncology, 2024, 34(9): 814-826.
|
[2] |
XU Rui, WANG Zehao, WU Jiong.
Advances in the role of tumor-associated neutrophils in the development of breast cancer
[J]. China Oncology, 2024, 34(9): 881-889.
|
[3] |
CAO Xiaoshan, YANG Beibei, CONG Binbin, LIU Hong.
The progress of treatment for brain metastases of triple-negative breast cancer
[J]. China Oncology, 2024, 34(8): 777-784.
|
[4] |
ZHANG Jian.
Clinical consideration of two key questions in assessing menopausal status of female breast cancer patients
[J]. China Oncology, 2024, 34(7): 619-627.
|
[5] |
WANG Manli, CHEN Hui, DUAN Zhi, XU Qimei, LI Zhen.
A study on communication mechanism of lung cancer cells in tumor microenvironment mediated by pleckstrin-2/miR-196a signal axis
[J]. China Oncology, 2024, 34(7): 628-638.
|
[6] |
JIANG Dan, SONG Guoqing, WANG Xiaodan.
Study on the mechanism of mitochondrial dysfunction and CPT1A/ERK signal transduction pathway regulating malignant behavior in breast cancer
[J]. China Oncology, 2024, 34(7): 650-658.
|
[7] |
LIU Shuai, ZHANG Kai, ZHANG Xiaoqing, LUAN Wei.
An exploratory study on the perioperative treatment of locally advanced gastric cancer with combination of penpulimab, anlotinib and chemotherapy
[J]. China Oncology, 2024, 34(7): 659-668.
|
[8] |
LIAO Ziyi, PENG Yang, ZENG Beilei, MA Yingying, ZENG Li, GAN Kelun, MA Daiyuan.
Analysis of pathological remission degree and influencing factors of radical surgery after neoadjuvant immunotherapy combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
[J]. China Oncology, 2024, 34(7): 669-679.
|
[9] |
LIANG Yingyun, CHEN Jianhua.
Application progress of oncolytic virus combined with immunotherapy in the treatment of malignant tumors
[J]. China Oncology, 2024, 34(7): 686-694.
|
[10] |
HUANG Sijie, KANG Xun, LI Wenbin.
Clinical research progress of intrathecal therapy in the treatment of leptomeningeal metastasis
[J]. China Oncology, 2024, 34(7): 695-701.
|
[11] |
DONG Jianqiao, LI Kunyan, LI Jing, WANG Bin, WANG Yanhong, JIA Hongyan.
A study on mechanism of SIRT3 inducing endocrine drug resistance in breast cancer via deacetylating YME1L1
[J]. China Oncology, 2024, 34(6): 537-547.
|
[12] |
TANG Nan, HUANG Huixia, LIU Xiaojian.
Integrated single-cell sequencing and transcriptome sequencing to reveal a 9-gene prognostic signature of immune cells in colorectal cancer
[J]. China Oncology, 2024, 34(6): 548-560.
|
[13] |
HAO Xian, HUANG Jianjun, YANG Wenxiu, LIU Jinting, ZHANG Junhong, LUO Yubei, LI Qing, WANG Dahong, GAO Yuwei, TAN Fuyun, BO Li, ZHENG Yu, WANG Rong, FENG Jianglong, LI Jing, ZHAO Chunhua, DOU Xiaowei.
Establishment of primary breast cancer cell line as new model for drug screening and basic research
[J]. China Oncology, 2024, 34(6): 561-570.
|
[14] |
WANG Xiaocong, LI Ming.
The value of single-cell sequencing in oral squamous cell carcinoma research
[J]. China Oncology, 2024, 34(5): 501-508.
|
[15] |
XIN Meiyi, LIN Yuhong, ZHAO Kai.
Progress in the development of mRNA vaccine and its delivery systems for anti-tumor immunotherapy
[J]. China Oncology, 2024, 34(5): 509-516.
|